A lawsuit has been filed in Ontario against Bayer -the manufactures of Yaz and Yasmin
The lawsuit alleges that Canadian women were “kept in the dark” about the increased risk of blood clots, stroke, heart attack, gallbladder disease and other medical conditions they had from taking Yaz or Yasmin.
In the United States, similar cases have taken place. In March, Bayer paid up to $24 million U.S. dollars to settle gallbladder injury claims in Illinois, California, New Jersey and Pennsylvania. According to Reuters, plaintiffs who suffered gallbladder injuries would receive $2,000 while those who had their gallbladders removed would receive $3,000. A total of $1 Billion U.S. dollars will be divided among 4,800 women who said the pill caused blood clots that resulted in heart attack, strokes and other injuries.
However, in the United States, these cases are ultimately consolidated. ”In the U.S., most class actions never go to trial and instead if a class is successfully certified that it’s allowed to go forward as a class action, the defendant settles.” said Glenn Cohen, a Harvard law school professor.
In April 2012, the FDA (Food and Drug Administration) required Bayer to change the labels on Yaz and Yasmin birth control products to emphasize blood clot warnings.
Contact Our Yasmin Lawsuit Attorneys
An experienced Yaz and Yasmin lawsuit attorney can help you file a lawsuit to recover the compensation to which you are entitled. Our Yasmin lawyers have extensive experience with dangerous drug cases and have specifically handled many Yaz and Yasmin birth control claims.
Our legal team will represent you intelligently and aggressively. To speak with a trial-tested Yaz and Yasmin lawyer – one familiar with its side effects and capable of helping you obtain just compensation – contact our Yaz and Yasmin lawsuit attorneys today. We will protect your rights.
Yaz and Yasmin remain among Bayer’s top selling pharmaceuticals despite the over 13,000 pending Yaz & Yasmin lawsuits.
According to the Bayer HealthCare Press Center:
The Bayer Group remains on a path of growth. “The upward trend in our life science businesses – HealthCare and CropScience – continued in the third quarter of 2012,” Management Board Chairman Dr. Marijn Dekkers said Tuesday following the publication of the interim report. HealthCare, particularly the Pharmaceuticals business, gained further growth momentum.
Sales of the Bayer Group advanced by 11.5 percent in the third quarter. The currency- and portfolio-adjusted (Fx & portfolio adj.) increase was 5.5 percent. Earnings before interest and taxes (EBIT) fell by 23.7 percent to EUR 838 million. Net special items totaled minus EUR 356 million. Included here were EUR 205 million in further accounting measures taken – mainly based on additional claims asserted but not filed in court – for all cases in connection with the oral contraceptive Yasmin™/YAZ™ of which Bayer is currently aware and which the company considers to be worthy of settlement (venous clot injuries). Among the other special charges were EUR 134 million in restructuring expenses.
To read the full report click here.
Bayer’s highest-selling products include:
- Betaferon – Multiple sclerosis
- Yaz / Yasmin / Yasminella – Hormonal Contraceptive
- Kogenate – Hemophilia
- Nexavar – Cancer
- Adalat – Hypertension
- Mirena – Hormonal Contraceptive
- Avalox – Respiratory Tract Infections
- Levitra – Erectile Dysfunction
- Aspirin Cardio
- Glucobay – Diabetes
You have the right to trust your medication is safe. Tragically, this is not always the case.
Anyone who suffered a blood clot, DVT (Deep Vein Thrombosis), stroke or Pulmonary Embolism after taking Yaz or Yasmin is strongly urged to contact a court appointed Yaz MDL (Multidistrict Litigation) attorney. Steve Maher is a court appointed Yaz MDL Attorney. He represent you, not drug manufacturers or insurance companies.
We invite you to contact The Maher Law Firm or Frank Eidson Attorney At Law today.